{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:12:49Z","timestamp":1790190769371,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Health Service (NHS) National Specialised Commissioning Group for Congenital Myasthenia (PMRC)"},{"name":"Watney\/MGA\/NIHR fellowship HMRVGX0 (SH)"},{"name":"NIHR Oxford Biomedical Research Centre (AV)"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.expneurol.2015.01.011","type":"journal-article","created":{"date-parts":[[2015,3,15]],"date-time":"2015-03-15T00:00:19Z","timestamp":1426377619000},"page":"66-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"special_numbering":"C","title":["Use of cell-based assays in myasthenia gravis and other antibody-mediated diseases"],"prefix":"10.1016","volume":"270","author":[{"given":"P.M.","family":"Rodriguez Cruz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Huda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"L\u00f3pez-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2015.01.011_bb0005","article-title":"COOH-terminal collagen Q (COLQ) mutants causing human deficiency of endplate acetylcholinesterase impair the interaction of ColQ with proteins of the basal lamina","author":"Arredondo","year":"2013","journal-title":"Hum. Genet."},{"key":"10.1016\/j.expneurol.2015.01.011_bb0010","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1212\/01.wnl.0000228225.23349.5d","article-title":"Anti-MuSK antibodies: correlation with myasthenia gravis severity","volume":"67","author":"Bartoccioni","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2015.01.011_bb0015","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1083\/jcb.200307164","article-title":"MuSK is required for anchoring acetylcholinesterase at the neuromuscular junction","volume":"165","author":"Cartaud","year":"2004","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.expneurol.2015.01.011_bb9015","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1093\/brain\/awu142","article-title":"Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes","volume":"137","author":"Carvajal-Gonz\u00e1lez","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2015.01.011_bb0020","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1749-6632.2012.06833.x","article-title":"The search for new antigenic targets in myasthenia gravis","volume":"1275","author":"Cossins","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2015.01.011_bb0025","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/ene.12270","article-title":"Antibodies to clustered acetylcholine receptor: expanding the phenotype","volume":"21","author":"Devic","year":"2014","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.expneurol.2015.01.011_bb0030","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/brain\/awg223","article-title":"Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis","volume":"126","author":"Evoli","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2015.01.011_bb0035","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.autrev.2014.08.039","article-title":"Cortactin autoantibodies in myasthenia gravis","volume":"13","author":"Gallardo","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.expneurol.2015.01.011_bb0040","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1212\/WNL.0000000000000478","article-title":"Anti-agrin autoantibodies in myasthenia gravis","volume":"82","author":"Gasperi","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2015.01.011_bb0045","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1474-4422(13)70282-5","article-title":"Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study","volume":"13","author":"Gresa-Arribas","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2015.01.011_bb0055","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ana.22312","article-title":"Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis","volume":"69","author":"Higuchi","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2015.01.011_bb0060","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ana.24200","article-title":"Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms","volume":"76","author":"Irani","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2015.01.011_bb0065","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1001\/archneurol.2012.437","article-title":"Presence and pathogenic relevance of antibodies to clustered acetylcholine receptor in ocular and generalized myasthenia gravis","volume":"69","author":"Jacob","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.expneurol.2015.01.011_bb0070","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1093\/brain\/awn240","article-title":"Antibody to aquaporin-4 in the long-term course of neuromyelitis optica","volume":"131","author":"Jarius","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2015.01.011_bb0075","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1212\/WNL.0b013e318237f660","article-title":"Anti-MuSK autoantibodies block binding of collagen Q to MuSK","volume":"77","author":"Kawakami","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2015.01.011_bb0080","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/ana.410150214","article-title":"Enzyme-linked immunosorbent assay for antibody against the nicotinic acetylcholine receptor in human myasthenia gravis","volume":"15","author":"Kawanami","year":"1984","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2015.01.011_bb0085","doi-asserted-by":"crossref","first-page":"e80695","DOI":"10.1371\/journal.pone.0080695","article-title":"MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters","volume":"8","author":"Koneczny","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2015.01.011_bb0095","series-title":"IgG1 antibodies to acetylcholine receptors in \u201cseronegative\u201d myasthenia gravis y 1940\u20131952","author":"Leite","year":"2008"},{"key":"10.1016\/j.expneurol.2015.01.011_bb0090","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1212\/WNL.0b013e31825644ff","article-title":"Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients","volume":"78","author":"Leite","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2015.01.011_bb0100","doi-asserted-by":"crossref","first-page":"e8478","DOI":"10.1371\/journal.pone.0008478","article-title":"The function of cortactin in the clustering of acetylcholine receptors at the vertebrate neuromuscular junction","volume":"4","author":"Madhavan","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2015.01.011_bb0105","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1212\/WNL.28.3.266","article-title":"Function of circulating antibody to acetylcholine receptor in myasthenia gravis: investigation by plasma exchange","volume":"28","author":"Newsom-Davis","year":"1978","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2015.01.011_bb0110","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1083\/jcb.105.6.2471","article-title":"Identification of agrin, a synaptic organizing protein from Torpedo electric organ","volume":"105","author":"Nitkin","year":"1987","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.expneurol.2015.01.011_bb0115","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/practneurol-2012-000237","article-title":"A practical guide to the treatment of neuromyelitis optica","volume":"12","author":"Palace","year":"2012","journal-title":"Pract. Neurol."},{"key":"10.1016\/j.expneurol.2015.01.011_bb0120","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00415-011-6194-7","article-title":"Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis","volume":"259","author":"Pevzner","year":"2012","journal-title":"J. Neurol."},{"key":"10.1016\/j.expneurol.2015.01.011_bb9000","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.expneurol.2014.12.013","article-title":"Guidelines for pre-clinical animal and cellular models of MuSK-myasthenia gravis","volume":"270","author":"Phillips","year":"2015","journal-title":"Exp. Neurol"},{"key":"10.1016\/j.expneurol.2015.01.011_bb0130","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/nmeth.1855","article-title":"Immunolabeling artifacts and the need for live-cell imaging","volume":"9","author":"Schnell","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.expneurol.2015.01.011_bb0135","doi-asserted-by":"crossref","first-page":"5190","DOI":"10.1172\/JCI66039","article-title":"Antibodies against low-density lipoprotein receptor-related protein 4 induce myasthenia gravis","volume":"123","author":"Shen","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.expneurol.2015.01.011_bb0140","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1136\/jnnp.48.12.1246","article-title":"Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays","volume":"48","author":"Vincent","year":"1985","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.expneurol.2015.01.011_bb0145","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1749-6632.2012.06789.x","article-title":"Antibodies identified by cell-based assays in myasthenia gravis and associated diseases","volume":"1274","author":"Vincent","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2015.01.011_bb0150","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1212\/WNL.0b013e318248dec1","article-title":"Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays","volume":"78","author":"Waters","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2015.01.011_bb0155","series-title":"Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays","first-page":"665","author":"Waters","year":"2012"},{"key":"10.1016\/j.expneurol.2015.01.011_bb0160","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2015.01.011_bb0165","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jns.2010.10.023","article-title":"Non-radioactive serological diagnosis of myasthenia gravis and clinical features of patients from Tianjin, China","volume":"301","author":"Yang","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2015.01.011_bb0170","article-title":"Clinical relevance of serum antibodies to extracellular N-methyl-d-aspartate receptor epitopes","author":"Zandi","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.expneurol.2015.01.011_bb0185","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archneurol.2011.2393","article-title":"Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis","volume":"69","author":"Zhang","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.expneurol.2015.01.011_bb0180","doi-asserted-by":"crossref","first-page":"e91816","DOI":"10.1371\/journal.pone.0091816","article-title":"Autoantibodies to agrin in myasthenia gravis patients","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488615000758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488615000758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T14:51:53Z","timestamp":1617461513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488615000758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":36,"alternative-id":["S0014488615000758"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2015.01.011","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of cell-based assays in myasthenia gravis and other antibody-mediated diseases","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2015.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}